Chromosomal numerical abnormality profiles of gastrointestinal stromal tumors. 2006

Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
Department of Pathology, Hamamatsu University School of Medicine, Shizuoka 431-3192, Japan.

BACKGROUND Biological variations in and the heterogeneity of gastrointestinal stromal tumors (GISTs) are well known, but chromosomal numerical abnormality (CNA) has not been fully examined especially in this context. The aim of this study is to test CNA as a possible biological predictor of biological behavior of GISTs. METHODS We applied microwave-assisted FISH protocol to pathological archives of GIST tumors displaying different clinical features to characterize the CNA profile of these tumors. A panel of 18 centromere enumeration probes (CEP) and 24 bacterial artificial chromosome (BAC) or P1-derived artificial chromosome (PAC) probes containing genes like Aurora kinases (AURKs) and other candidate genes involved in human carcinogenesis were used. CNA profiles, histopathological risk categorization and Ki-67 labeling indexes of 23 primary and/or metastatic GIST tumors of 12 subjects (both primary and metastatic in 7 subjects) were compared between primary GIST with and without metastases, and between metastatic and primary portions in 7 individuals. RESULTS CNA in the primary sites was more extensive in the GISTs with recurrence and metastasis than in those without, especially as to the loss of chromosome 20 and genomic imbalance of AURKA-containing BAC probe on 20q in the cases with metastasis. The consistent loss of one allele of chromosome 14q was also noted. Interestingly, both primary and metastatic tumors in identical individuals had similar CNA profiles. CONCLUSIONS The extent of CNA differed between GISTS with and without recurrence or metastasis; thus, FISH analysis of specimens from the primary sites may predict the biological behavior of this tumor.

UI MeSH Term Description Entries
D008297 Male Males
D008872 Microwaves That portion of the electromagnetic spectrum from the UHF (ultrahigh frequency) radio waves and extending into the INFRARED RAYS frequencies. EHF Waves,Extremely High Frequency Radio Waves,Micro Wave,Micro Waves,Ultrahigh Frequency Waves,Microwave Radiation,EHF Wave,Micro Waves,Microwave,Microwave Radiations,Radiation, Microwave,Ultrahigh Frequency Wave,Wave, EHF,Wave, Micro,Wave, Ultrahigh Frequency,Waves, Micro
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH

Related Publications

Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2014, Human pathology,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2004, Journal of biomedical science,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
August 1979, The New England journal of medicine,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2011, Annali italiani di chirurgia,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2008, Chirurgia (Bucharest, Romania : 1990),
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2012, Current topics in microbiology and immunology,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2011, Annali italiani di chirurgia,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2012, Arkhiv patologii,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
August 2000, Current treatment options in oncology,
Kimihiro Yamashita, and Hisaki Igarashi, and Yasuhiko Kitayama, and Takachika Ozawa, and Shinichiro Kiyose, and Hiroyuki Konno, and Teruhisa Kazui, and Shumpei Ishikawa, and Hiroyuki Aburatani, and Fumihiko Tanioka, and Masaya Suzuki, and Haruhiko Sugimura
January 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!